Merck Press Releases - EIN Presswire - Press Release Distribution Service

Published on April 10, 2013 - 12:59 GMT

Merck Announces FDA Acceptance of New Drug Application for an Investigational Tablet Formulation of the Antifungal NOXAFIL® (...

WHITEHOUSE STATION N.J.--(BUSINESS WIRE)--Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced that its New Drug Application for an investigational, tablet formulation of the company's antifungal agent, NOXAFIL® ( …

Distribution channels: Companies

Published on April 8, 2013 - 15:24 GMT

Merck to Present New Data on VICTRELIS® (boceprevir) and Investigational Compounds MK-5172 and Vaniprevir for Chronic Hepatitis C ...

WHITEHOUSE STATION, N.J.--(BUSINESS WIRE)-- Merck (NYSE: MRK), known as MSD outside of the United States and Canada, announced today that two analyses of VICTRELIS (boceprevir) and data from Phase II studies of two of Merck’s investigational medicines for …

Distribution channels: Companies

Published on April 1, 2013 - 12:49 GMT

Merck to Hold First-Quarter 2013 Sales and Earnings Conference Call on May 1

WHITEHOUSE STATION, N.J.--(BUSINESS WIRE)--Merck (NYSE: MRK), known as MSD outside the United States and Canada, will hold its first-quarter 2013 sales and earnings conference call with institutional investors and analysts at 8:00 a.m. EDT on Wednesday, …

Distribution channels: Companies

Published on March 27, 2013 - 12:27 GMT

Merck Announces FDA Acceptance of Biologics License Application for Investigational Grass Pollen Allergy Immunotherapy Tablet

WHITEHOUSE STATION, N.J.--(BUSINESS WIRE)--Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced that the Biologics License Application (BLA) for its investigational Timothy grass pollen (Phleum pratense) allergy …

Distribution channels: Companies

Published on March 18, 2013 - 18:33 GMT

Mistrial Declared in FOSAMAX® (alendronate sodium) New Jersey State Court Trial

Merck, known outside the United States and Canada as MSD, today said a mistrial was declared by Judge Carol E. Higbee of the Superior Court for Atlantic County, N.J., in the Su v. Merck case. One week after opening statements were given, the plaintiff …

Distribution channels: Companies

Published on March 13, 2013 - 13:47 GMT

Merck and Luminex Corporation Enter Agreement to Develop Companion Diagnostic to Support Investigational BACE inhibitor Clinical ...

WHITEHOUSE STATION, N.J. AUSTIN, Texas--(BUSINESS WIRE)--Merck (NYSE: MRK), known as MSD outside the United States and Canada, and Luminex Corporation (NASDAQ:LMNX) have signed a collaboration and license agreement to develop a companion diagnostic device …

Distribution channels: Companies

Published on March 12, 2013 - 12:11 GMT

Merck Provides Update on IMPROVE-IT Trial

WHITEHOUSE STATION, N.J.--(BUSINESS WIRE)--Merck (NYSE:MRK), known as MSD outside the United States and Canada, today said that the Data Safety Monitoring Board (DSMB) of the IMPROVE-IT trial has completed its planned review of study data and recommended …

Distribution channels: Companies

Published on March 11, 2013 - 14:28 GMT

Statement on FOSAMAX® (alendronate sodium) Product Liability Trial

Merck, known as MSD outside the United States and Canada, will vigorously defend itself in a jury trial set to begin today in the Superior Court of New Jersey in Atlantic County. InSu v. Merck, the plaintiff alleges she used FOSAMAX and sustained an …

Distribution channels: Companies

Published on March 9, 2013 - 18:39 GMT

Results from HPS2-THRIVE Study of TREDAPTIVE™ (extended-release niacin/laropiprant) Presented at American College of Cardiology ...

SAN FRANCISCO--(BUSINESS WIRE)--Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced that researchers from the Clinical Trial Service Unit at Oxford University presented results from the HPS2-THRIVE (Heart Protection Study …

Distribution channels: Companies

Published on March 7, 2013 - 12:44 GMT

Merck Announces Appointment of Roger M. Perlmutter, M.D., Ph.D., As President of Merck Research Laboratories; Peter S. Kim, Ph.D., ...

WHITEHOUSE STATION, N.J.--(BUSINESS WIRE)--Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced the appointment of Roger M. Perlmutter, M.D., Ph.D., as executive vice president and president of Merck Research Laboratories ( …

Distribution channels: Companies

Published on March 5, 2013 - 14:01 GMT

Merck to Present at the 33rd Annual Cowen Health Care Conference

WHITEHOUSE STATION, N.J.--(BUSINESS WIRE)--Merck (NYSE: MRK), known as MSD outside the United States and Canada, announced today that Peter N. Kellogg, executive vice president and chief financial officer, Merck, is scheduled to present at the 33rd Annual …

Distribution channels: Companies

Published on February 28, 2013 - 14:53 GMT

Bruce Kuhlik and Merck Honored by PBI for Commitment to Pro Bono

Merck, known as MSD outside the United States and Canada, today announced that the Pro Bono Institute (PBI) has selected Executive Vice President and General Counsel Bruce Kuhlik and the company’s legal department as the winner of the 2013 Laurie D. Zelon …

Distribution channels: Companies

Published on February 27, 2013 - 16:00 GMT

Merck Announces Second-Quarter 2013 Dividend

WHITEHOUSE STATION, N.J.--(BUSINESS WIRE)--Merck, known as MSD outside the United States and Canada, today announced that the Board of Directors has declared a quarterly dividend of $0.43 per share on the company’s common stock for the second quarter of …

Distribution channels: Companies

Published on February 26, 2013 - 13:40 GMT

Merck to Present at the Citi 2013 Global Healthcare Conference

WHITEHOUSE STATION, N.J.--(BUSINESS WIRE)--Merck (NYSE: MRK), known as MSD outside the United States and Canada, announced today that Peter N. Kellogg, executive vice president and chief financial officer, Merck, is scheduled to present at the Citi 2013 …

Distribution channels: Companies

Published on February 26, 2013 - 12:01 GMT

Merck and AstraZeneca Agree to Amend Partnership

WHITEHOUSE STATION, N.J.--(BUSINESS WIRE)--Merck (NYSE: MRK), known as MSD outside the United States and Canada, announced today that Merck and AstraZeneca have amended the option agreement related to their partnership known as AstraZeneca LP (AZLP).The …

Distribution channels: Companies

Published on February 26, 2013 - 12:01 GMT

Merck Recognizes World Hepatitis Day with Partnerships and Grants to Support Global and U.S. Hepatitis C Communities

In honor of World Hepatitis Day on July 28, Merck (NYSE: MRK) (known as MSD outside the United States and Canada) today announced updates on several projects supporting the global and U.S. hepatitis C communities as part of its Hope Against Hepatitis C …

Distribution channels: Companies

Published on February 26, 2013 - 12:01 GMT

Merck to Present at Morgan Stanley Global Healthcare Conference

WHITEHOUSE STATION, N.J.--(BUSINESS WIRE)--Merck (NYSE: MRK), known as MSD outside the United States and Canada, announced today that Adam H. Schechter, executive vice president and president, Global Human Health is scheduled to present at the Morgan …

Distribution channels: Companies

Published on February 26, 2013 - 12:01 GMT

Merck Prices $2.5 Billion Debt Offering

WHITEHOUSE STATION, N.J.--(BUSINESS WIRE)-- Merck Co., Inc. priced today a $2.5 billion public offering of senior unsecured notes. The notes include: $1.0 billion of 1.100% notes due 2018 $1.0 billion of 2.400% notes due 2022 $500.0 million of 3.600% notes …

Distribution channels: Companies

Published on February 26, 2013 - 12:01 GMT

Merck Resolves Previously Disclosed Missouri Consumer Class Action Lawsuit Related to Vioxx

WHITEHOUSE STATION, N.J.--(BUSINESS WIRE)--Merck, known as MSD outside the United States and Canada, today confirmed terms of an agreement with plaintiffs to resolve Plubell v. Merck, an economic class action lawsuit pending in Missouri state court. The …

Distribution channels: Companies

Published on February 26, 2013 - 12:01 GMT

Merck and Regenstrief Institute Establish Evidence-Based Care Collaboration

WHITEHOUSE, N.J., and INDIANAPOLIS--(BUSINESS WIRE)--The Regenstrief Institute and Merck, known as MSD outside the United States and Canada, have signed a five-year agreement to collaborate on a range of projects that will use clinical data to inform …

Distribution channels: Companies